Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Insa E Emrich

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Amino Acids|July 9, 2018
L-Homoarginine and its AGXT2-metabolite GOCA in chronic kidney disease as markers for clinical status and prognosisJens Martens-Lobenhoffer, Insa E Emrich, Adam M Zawada, et al.
Kidney International|February 19, 2015
High estimated pulmonary artery systolic pressure predicts adverse cardiovascular outcomes in stage 2-4 chronic kidney diseaseDavide Bolignano, Simone Lennartz, Daniela Leonardis, et al.
Journal of the American College of Cardiology|January 14, 2017
HDL Cholesterol Efflux Capacity and Cardiovascular Events in Patients With Chronic Kidney DiseaseLucie Bauer, Sabine Kern, Kyrill S Rogacev, et al.
Hypertension (Dallas, Tex. : 1979)|April 4, 2024
Impact of Renal Denervation on Urinary Peptide-Based Biomarkers in HypertensionLucas Lauder, Justyna Siwy, Emmanouil Mavrogeorgis, et al.
Pharmacology Research & Perspectives|June 15, 2021
Markers of cholesterol synthesis to cholesterol absorption across the spectrum of non-dialysis CKD: An observational studyInsa E Emrich, Gunnar H Heine, P Christian Schulze, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 11, 2018
Do plasma neprilysin activity and plasma neprilysin concentration predict cardiac events in chronic kidney disease patients?Insa E Emrich, Nicolas Vodovar, Linda Feuer, et al.
Journal of Lipid Research|May 24, 2018
HDL functionality and cardiovascular outcome among nondialysis chronic kidney disease patientsKathrin Untersteller, Sabine Meissl, Markus Trieb, et al.
Clinical Kidney Journal|April 4, 2022
Plasma biomarkers outperform echocardiographic measurements for cardiovascular risk prediction in kidney transplant recipients: results of the HOME ALONE studyInsa E Emrich, Anja L Scheuer, Kyrill S Rogacev, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|October 27, 2019
Does a rise in plasma erythropoietin after high-altitude exposure affect FGF23 in healthy volunteers on a normal or low-phosphorus diet?Insa E Emrich, Juliane Dederer, Angelika Kircher, et al.
American Journal of Nephrology|May 19, 2016
Best Albuminuria Measurement to Predict Cardiovascular and Renal EventsLucie Bauer, Insa E Emrich, John W Pickering, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Amino Acids|July 9, 2018
L-Homoarginine and its AGXT2-metabolite GOCA in chronic kidney disease as markers for clinical status and prognosisJens Martens-Lobenhoffer, Insa E Emrich, Adam M Zawada, et al.
Kidney International|February 19, 2015
High estimated pulmonary artery systolic pressure predicts adverse cardiovascular outcomes in stage 2-4 chronic kidney diseaseDavide Bolignano, Simone Lennartz, Daniela Leonardis, et al.
Journal of the American College of Cardiology|January 14, 2017
HDL Cholesterol Efflux Capacity and Cardiovascular Events in Patients With Chronic Kidney DiseaseLucie Bauer, Sabine Kern, Kyrill S Rogacev, et al.
Hypertension (Dallas, Tex. : 1979)|April 4, 2024
Impact of Renal Denervation on Urinary Peptide-Based Biomarkers in HypertensionLucas Lauder, Justyna Siwy, Emmanouil Mavrogeorgis, et al.
Pharmacology Research & Perspectives|June 15, 2021
Markers of cholesterol synthesis to cholesterol absorption across the spectrum of non-dialysis CKD: An observational studyInsa E Emrich, Gunnar H Heine, P Christian Schulze, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 11, 2018
Do plasma neprilysin activity and plasma neprilysin concentration predict cardiac events in chronic kidney disease patients?Insa E Emrich, Nicolas Vodovar, Linda Feuer, et al.
Journal of Lipid Research|May 24, 2018
HDL functionality and cardiovascular outcome among nondialysis chronic kidney disease patientsKathrin Untersteller, Sabine Meissl, Markus Trieb, et al.
Clinical Kidney Journal|April 4, 2022
Plasma biomarkers outperform echocardiographic measurements for cardiovascular risk prediction in kidney transplant recipients: results of the HOME ALONE studyInsa E Emrich, Anja L Scheuer, Kyrill S Rogacev, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|October 27, 2019
Does a rise in plasma erythropoietin after high-altitude exposure affect FGF23 in healthy volunteers on a normal or low-phosphorus diet?Insa E Emrich, Juliane Dederer, Angelika Kircher, et al.
American Journal of Nephrology|May 19, 2016
Best Albuminuria Measurement to Predict Cardiovascular and Renal EventsLucie Bauer, Insa E Emrich, John W Pickering, et al.
Pageof 4